Zoetis Downgraded to Market Perform by Leerink Analyst Daniel Clark
ByAinvest
Thursday, Jul 17, 2025 11:59 pm ET1min read
PIPR--
The move comes amidst a mixed bag of analyst ratings for Zoetis. While several analysts have maintained a positive outlook on the stock, others have adjusted their ratings. For instance, Piper Sandler increased their target price from $205 to $210 and gave the stock an "overweight" rating [1]. Meanwhile, Stifel Nicolaus cut its rating from "buy" to "hold" and lowered the price target from $165 to $160 [1]. UBS Group also reduced their target price from $189 to $170 and set a "neutral" rating [1].
Zoetis reported strong earnings for the first quarter of 2025, with 9% organic operational revenue growth led by the International segment. The Companion Animal portfolio also saw 9% operational growth, driven by sustained demand for market-leading franchises. However, the company faced challenges in the US Livestock segment, which experienced a 2% organic operational decline due to aggressive price competition and timing of price adjustments [2].
The downgrade by Leerink Partners suggests that investors should be cautious about Zoetis' near-term prospects. However, the company's strong earnings performance and global scale may provide a buffer against potential headwinds. As always, investors should conduct thorough research and consider their risk tolerance before making investment decisions.
References:
[1] https://www.marketbeat.com/instant-alerts/zoetis-nysezts-downgraded-by-leerink-partners-to-market-perform-2025-07-17/
[2] https://www.gurufocus.com/news/2983345/zoetis-zts-downgraded-to-market-perform-by-analyst-zts-stock-news
UBS--
ZTS--
Leerink analyst Daniel Clark downgraded Zoetis (ZTS) to Market Perform from Outperform with a $155 price target.
Zoetis (NYSE:ZTS) has been downgraded to a "Market Perform" rating by Leerink analyst Daniel Clark, who previously had the stock rated as "Outperform." The analyst has set a new price target of $155 for the stock [1]. This downgrade reflects a more cautious outlook on the company's future performance, indicating that Zoetis might not surpass broader market expectations.The move comes amidst a mixed bag of analyst ratings for Zoetis. While several analysts have maintained a positive outlook on the stock, others have adjusted their ratings. For instance, Piper Sandler increased their target price from $205 to $210 and gave the stock an "overweight" rating [1]. Meanwhile, Stifel Nicolaus cut its rating from "buy" to "hold" and lowered the price target from $165 to $160 [1]. UBS Group also reduced their target price from $189 to $170 and set a "neutral" rating [1].
Zoetis reported strong earnings for the first quarter of 2025, with 9% organic operational revenue growth led by the International segment. The Companion Animal portfolio also saw 9% operational growth, driven by sustained demand for market-leading franchises. However, the company faced challenges in the US Livestock segment, which experienced a 2% organic operational decline due to aggressive price competition and timing of price adjustments [2].
The downgrade by Leerink Partners suggests that investors should be cautious about Zoetis' near-term prospects. However, the company's strong earnings performance and global scale may provide a buffer against potential headwinds. As always, investors should conduct thorough research and consider their risk tolerance before making investment decisions.
References:
[1] https://www.marketbeat.com/instant-alerts/zoetis-nysezts-downgraded-by-leerink-partners-to-market-perform-2025-07-17/
[2] https://www.gurufocus.com/news/2983345/zoetis-zts-downgraded-to-market-perform-by-analyst-zts-stock-news
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet